Related references
Note: Only part of the references are listed.Protective effects of a small-molecule inhibitor DDQ against tau-induced toxicities in a transgenic tau mouse model of Alzheimer's disease
Murali Vijayan et al.
HUMAN MOLECULAR GENETICS (2022)
Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer's Disease
Sudhir Kshirsagar et al.
CELLS (2022)
Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease
Sudhir Kshirsagar et al.
HUMAN MOLECULAR GENETICS (2022)
A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer disease
Ramesh Kandimalla et al.
HUMAN MOLECULAR GENETICS (2022)
Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria
Albin John et al.
AGEING RESEARCH REVIEWS (2021)
Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease
Arubala P. Reddy et al.
HUMAN MOLECULAR GENETICS (2021)
Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease
Sudhir Kshirsagar et al.
PHARMACOLOGICAL RESEARCH (2021)
MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease
Subodh Kumar et al.
REDOX BIOLOGY (2021)
Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease
Arubala P. Reddy et al.
HUMAN MOLECULAR GENETICS (2021)
Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer's disease-like pathology
David Baglietto-Vargas et al.
NATURE COMMUNICATIONS (2021)
Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse
Hallie Morton et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease
Murali Vijayan et al.
MITOCHONDRION (2021)
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances
Wenzhang Wang et al.
MOLECULAR NEURODEGENERATION (2020)
Defective mitophagy in Alzheimer's disease
Jangampalli Adi Pradeepkiran et al.
AGEING RESEARCH REVIEWS (2020)
Molecular Basis of Alzheimer's Disease: Focus on Mitochondria
Darryll M. A. Oliver et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice
Zhuo Gong et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease
Evandro F. Fang et al.
NATURE NEUROSCIENCE (2019)
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease
P. Hemachandra Reddy et al.
CELLS (2019)
Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease
Ramesh Kandimalla et al.
HUMAN MOLECULAR GENETICS (2018)
Neuroprotective Effects of Kinetin Against Glutamate-Induced Oxidative Cytotoxicity in HT22 Cells: Involvement of Nrf2 and Heme Oxygenase-1
Yunpeng Wei et al.
NEUROTOXICITY RESEARCH (2018)
Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease
P. Hemachandra Reddy et al.
HUMAN MOLECULAR GENETICS (2018)
Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer's disease
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2018)
Epigallocatechin Gallate Attenuates β-Amyloid Generation and Oxidative Stress Involvement of PPARγ in N2a/APP695 Cells
Zhao-Xu Zhang et al.
NEUROCHEMICAL RESEARCH (2017)
Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease (vol 26, pg 1483, 2017)
P. Hemachandra Reddy et al.
HUMAN MOLECULAR GENETICS (2017)
The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer's disease: an overview of pre-clinical studies and translational perspectives in clinical practice
Marco Cascella et al.
INFECTIOUS AGENTS AND CANCER (2017)
Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons
Adrianne S. Chesser et al.
NUTRITIONAL NEUROSCIENCE (2016)
Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease
Ramesh Kandimalla et al.
HUMAN MOLECULAR GENETICS (2016)
Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2016)
(-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression
Xiang Chang et al.
EXPERIMENTAL CELL RESEARCH (2015)
The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives
Russell H. Swerdlow et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines
Diana F. Silva et al.
HUMAN MOLECULAR GENETICS (2013)
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics
P. Hemachandra Reddy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimers disease neurons: implications for mitochondrial dysfunction and neuronal damage
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2012)
Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimers disease
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2012)
Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage
Maria Manczak et al.
HUMAN MOLECULAR GENETICS (2011)
Amyloid-beta and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline
P. Hemachandra Reddy et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Alzheimer's disease mitochondrial cascade hypothesis: An update
Russell H. Swerdlow et al.
EXPERIMENTAL NEUROLOGY (2009)
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Xinglong Wang et al.
JOURNAL OF NEUROSCIENCE (2009)
Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease
Heng Du et al.
NATURE MEDICINE (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins
Xinglong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models
P. Hemachandra Reddy et al.
NEUROBIOLOGY OF AGING (2006)
ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease
JW Lustbader et al.
SCIENCE (2004)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
Mitochondrial abnormalities in Alzheimer's disease
K Hirai et al.
JOURNAL OF NEUROSCIENCE (2001)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
Share Paper
